Inventor · disambiguated record
Jayaraman Chandrasekhar
Also filed as: CHANDRASEKHAR JAYARAMAN
20 granted patents·10 pending applications·58 citations·filing 2009–2024
92Inventor score
Top patents by PatentIndex Score
30 records- 0194US11224600B2Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2019·Granted Jan 18, 2022·9 cites·21 claims
- 0293US11897878B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Feb 13, 2024·2 cites·65 claims
- 0392US11925631B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Mar 12, 2024·2 cites·37 claims
- 0491US9376441B2Substituted pyrrolidines as SYK inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Jun 28, 2016·17 cites·20 claims
- 0589US11453681B2Substituted eneoxindoles and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Sep 27, 2022·2 cites·53 claims
- 0689US11179383B2Compounds for inhibition of α4β7 integrinGILEAD SCIENCES INC·Filed 2019·Granted Nov 23, 2021·3 cites·20 claims
- 0789US11071730B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2019·Granted Jul 27, 2021·4 cites·40 claims
- 0888US11203591B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2019·Granted Dec 21, 2021·6 cites·45 claims
- 0983US11174256B2Imidazopyridine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Nov 16, 2021·2 cites·18 claims
- 1083US11116760B2Quinoline derivativesGILEAD SCIENCES INC·Filed 2019·Granted Sep 14, 2021·3 cites·23 claims
- 1183US10005774B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 26, 2018·4 cites·9 claims
- 1279US11578069B2Compounds for inhibition of α4 β7 integrinGILEAD SCIENCES INC·Filed 2020·Granted Feb 14, 2023·1 cites·11 claims
- 1378US12258346B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2023·Granted Mar 25, 2025·0 cites·23 claims
- 1477US10227350B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Granted Mar 12, 2019·3 cites·19 claims
- 1577US2025032473A1Quinoline derivativesGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1673US2025163030A1Pyridizin-3(2h)-one derivativesGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1770US12037342B2Substituted eneoxindoles and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Jul 16, 2024·0 cites·54 claims
- 1868US12053462B2Quinoline derivativesGILEAD SCIENCES INC·Filed 2021·Granted Aug 6, 2024·0 cites·18 claims
- 1967US12459922B2PARP7 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Nov 4, 2025·0 cites·16 claims
- 2066US2023183216A1Pyridizin-3(2h)-one derivativesGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 2165US2022226337A1Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2265US2022152014A1Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2363US2022135561A1Imidazopyridine derivativesGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2462US2025100998A1Parp7 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2562US2025066328A1Parp7 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2646US8445684B2Nicotinic acetylcholine receptor ligands and the uses thereofCHANDRASEKHAR JAYARAMAN·Filed 2009·Granted May 21, 2013·0 cites·19 claims
- 2745US10479770B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Granted Nov 19, 2019·0 cites·13 claims
- 2843US2013338142A1Imidazopyrazine syk inhibitorsGILEAD CONNECTICUT INC·Filed 2013·Application pending·0 cites
- 2941US10214519B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Granted Feb 26, 2019·0 cites·20 claims
- 3037US2013184313A1Nicotinic acetylcholine receptor ligands and the uses thereofCHANDRASEKHAR JAYARAMAN·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jayaraman Chandrasekhar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →